[ad_1] SpringWorks Therapeutics Inc. shares SWTX were on track for a record percentage gain on…
Medical Treatments/Procedures
-
-
STOCK MARKET
Verve Therapeutics stock falls 40% as analysts question safety of cholesterol-cutting gene-editing treatment
by userby user[ad_1] Verve Therapeutics Inc. shares VERV, -44.39% fell 40% premarket on Monday after the biotech…
-
STOCK MARKET
BioNTech’s stock rallies after it posts surprise Q3 profit and revenue that tops estimates
by userby user[ad_1] BioNTech SE’s stock rose 2.5% early Monday after the company posted a surprise profit…
-
STOCK MARKET
Amgen gets FDA approval for its inflammatory diseases treatment Wezlana
by userby user[ad_1] Amgen AMGN, -2.85% has received approval from the U.S. Food and Drug Administration for…
-
STOCK MARKET
Biotech stocks are in a post-pandemic slump and recovery in 2024 is questionable
by userby user[ad_1] Novavax NVAX, +5.24% stands out as a stark reminder of the biotech sector’s faltering…
-
STOCK MARKET
Pfizer gets FDA green light for new shot that can streamline teenagers’ vaccinations
by userby user[ad_1] Pfizer Inc. PFE, -1.73% said Friday that the U.S. Food and Drug Administration has…
-
[ad_1] Ardelyx Inc. ARDX, -0.58% on Tuesday won its long fight for U.S. regulatory approval…
-
[ad_1] Sanofi SNY, -0.62% on Friday released positive trial results for its investigational eczema treatment,…
-
STOCK MARKET
Tempest Therapeutics’ stock jumps 1,900% as liver-cancer treatment shows promise
by userby user[ad_1] Shares of Tempest Therapeutics Inc. TPST soared more than 1,900% on Wednesday after the…
-
STOCK MARKET
Dialysis company shares plunge after Ozempic trial success vs. kidney trouble
by userby user[ad_1] Fixes story to correct spelling of analyst’s name. The trial success of Novo Nordisk’s…